Valuation : Precision Therapeutics Inc

Market Cap 129M 112M 106M 95.74M 180M 12.37B 181M 1.25B 482M 6.29B 486M 476M 19.88B P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 120M 104M 98.18M 88.99M 167M 11.5B 168M 1.17B 448M 5.85B 452M 442M 18.48B EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript : Precision Therapeutics Inc

Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 129M
-0.71%-6.35%-2.99%+9.59% 45.48B
+0.21%-2.98%+337.74%+519.55% 43.68B
+1.74%-2.24%+39.82%+20.76% 43.09B
+1.38%-3.28%+6.84%+67.62% 39.4B
-1.44%-5.26%+8.97%+39.76% 31.91B
+0.87%-2.60% - - 17.31B
+0.75%-0.64%+19.75%+110.17% 16.4B
-0.31%-2.78%+10.78%+31.02% 14.24B
+1.93%-3.55%+82.00%+41.17% 13.28B
Average -0.31%-3.20%+62.86%+104.96% 29.42B
Weighted average by Cap. +0.41%-3.50%+74.57%+124.26%

Financials

2024 2025
Net sales 1.62M 1.4M 1.32M 1.2M 2.25M 155M 2.26M 15.73M 6.05M 78.92M 6.1M 5.96M 249M 125K 108K 102K 92.64K 174K 11.97M 175K 1.21M 467K 6.09M 471K 460K 19.24M
Net income -12.66M -10.91M -10.33M -9.36M -17.57M -1.21B -17.66M -123M -47.19M -616M -47.56M -46.52M -1.95B -233M -201M -190M -172M -323M -22.27B -325M -2.26B -869M -11.33B -875M -856M -35.8B
Net Debt 1.4M 1.2M 1.14M 1.03M 1.94M 133M 1.95M 13.53M 5.2M 67.87M 5.24M 5.13M 214M -9.12M -7.86M -7.44M -6.75M -12.66M -872M -12.72M -88.41M -34M -443M -34.27M -33.52M -1.4B
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!